Access cutting-edge lupus nephritis treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access lupus nephritis specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus nephritis treatment provided free
This phase II, randomized, double-blind, placebo-controlled study is designed to evaluate the safety, efficacy and pharmacokinetics (PK) of obinutuzumab in adolescent participants (AP) aged 12 to less than 18 with biopsy-confirmed proliferative lupus nephritis (LN). It will also evaluate open label safety and PK of obinutuzumab in pediatric participants (PP), aged 5 to \<12 with LN.
Sponsor: Hoffmann-La Roche
Check if you qualify for this lupus nephritis clinical trial in San Francisco, CA
If you're searching for lupus nephritis treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.